These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30420919)

  • 1. What Are the Participants' Perspectives of Taking Melatonin for the Treatment of Nocturia in Multiple Sclerosis? A Qualitative Study Embedded within a Double-Blind RCT.
    Khan R; Uren A; Canham L; Cottrell D; Drake MJ; Cotterill N
    Mult Scler Int; 2018; 2018():4721505. PubMed ID: 30420919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS).
    Delgado D; Canham L; Cotterill N; Cottrell D; Drake MJ; Inglis K; Owen D; White P
    BMC Neurol; 2017 Mar; 17(1):63. PubMed ID: 28347292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS).
    Drake MJ; Canham L; Cotterill N; Delgado D; Homewood J; Inglis K; Johnson L; Kisanga MC; Owen D; White P; Cottrell D
    BMC Neurol; 2018 Aug; 18(1):107. PubMed ID: 30081859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participant experiences from chronic administration of a multivitamin versus placebo on subjective health and wellbeing: a double-blind qualitative analysis of a randomised controlled trial.
    Sarris J; Cox KH; Camfield DA; Scholey A; Stough C; Fogg E; Kras M; White DJ; Sali A; Pipingas A
    Nutr J; 2012 Dec; 11():110. PubMed ID: 23241329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial.
    Valiquette G; Herbert J; Maede-D'Alisera P
    Arch Neurol; 1996 Dec; 53(12):1270-5. PubMed ID: 8970454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement.
    Drake MJ; Mills IW; Noble JG
    J Urol; 2004 Mar; 171(3):1199-202. PubMed ID: 14767300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial.
    Leerasiri P; Pariyaeksut P; Hengrasmee P; Asumpinwong C
    Int Urogynecol J; 2023 Feb; 34(2):485-492. PubMed ID: 35596803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' Lived Experiences of Nocturia: A Qualitative Study of the Evening, the Night, and the Next Day.
    Trigg A; Andersson FL; Aldhouse NVJ; Bliwise DL; Kitchen H
    Patient; 2017 Dec; 10(6):711-718. PubMed ID: 28425062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort.
    Obayashi K; Saeki K; Kurumatani N
    J Urol; 2014 Jun; 191(6):1816-21. PubMed ID: 24384156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a Gentle, Self-Administered Stimulation of Perineal Skin for Nocturia in Elderly Women: A Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
    Iimura K; Watanabe N; Masunaga K; Miyazaki S; Hotta H; Kim H; Hisajima T; Takahashi H; Kasuya Y
    PLoS One; 2016; 11(3):e0151726. PubMed ID: 27003163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol.
    Adam R; Kanakarajan S; Onyeakazi U; Columb M; Galley H
    BMJ Open; 2020 Mar; 10(3):e034443. PubMed ID: 32184313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP; Zinner NR; Klein BM; Nørgaard JP
    Neurourol Urodyn; 2012 Apr; 31(4):441-7. PubMed ID: 22447415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of melatonin on physical fatigue and other symptoms in patients with advanced cancer receiving palliative care: A double-blind placebo-controlled crossover trial.
    Lund Rasmussen C; Klee Olsen M; Thit Johnsen A; Petersen MA; Lindholm H; Andersen L; Villadsen B; Groenvold M; Pedersen L
    Cancer; 2015 Oct; 121(20):3727-36. PubMed ID: 26178160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-Blind, Placebo-Controlled, Crossover Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia.
    Krystal AD; Preud'homme XA
    Sleep; 2017 Jan; 40(1):. PubMed ID: 28364461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploratory pilot study of exogenous sustained-release melatonin on nocturia in Parkinson's disease.
    Batla A; Simeoni S; Uchiyama T; deMin L; Baldwin J; Melbourne C; Islam S; Bhatia KP; Pakzad M; Eriksson S; Panicker JN
    Eur J Neurol; 2021 Jun; 28(6):1884-1892. PubMed ID: 33576095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
    Appleton RE; Jones AP; Gamble C; Williamson PR; Wiggs L; Montgomery P; Sutcliffe A; Barker C; Gringras P
    Health Technol Assess; 2012; 16(40):i-239. PubMed ID: 23098680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment for memory disorder in multiple sclerosis.
    He D; Zhang Y; Dong S; Wang D; Gao X; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008876. PubMed ID: 24343792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial aspects of the lived experience of multiple sclerosis: personal perspectives.
    Cowan CK; Pierson JM; Leggat SG
    Disabil Rehabil; 2020 Feb; 42(3):349-359. PubMed ID: 30261757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.